One third of hypertrophic cardiomyopathy cases in Finland are caused by one of the four major mutations, a new study shows. Overall, 40 percent of patients carried a specific or a likely mutation causing the disease, and 20 percent were carriers of a rare gene mutation whose role in the disease remains unknown.
